KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Exact Sciences (EXAS) EPS (Weighted Average and Diluted) (2019 - 2025)

Exact Sciences (EXAS) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.45 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 90.43% to -$0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.1, a 80.36% increase, with the full-year FY2025 number at -$1.1, up 80.32% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.45 for Q4 2025 at Exact Sciences, down from -$0.1 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q3 2023 to a low of -$4.7 in Q4 2024.
  • A 5-year average of -$0.74 and a median of -$0.5 in 2025 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): soared 100.51% in 2023, then plummeted 4968.48% in 2024.
  • Exact Sciences' EPS (Weighted Average and Diluted) stood at -$1.28 in 2021, then surged by 43.75% to -$0.72 in 2022, then soared by 63.89% to -$0.26 in 2023, then tumbled by 1707.69% to -$4.7 in 2024, then surged by 90.43% to -$0.45 in 2025.
  • Per Business Quant, the three most recent readings for EXAS's EPS (Weighted Average and Diluted) are -$0.45 (Q4 2025), -$0.1 (Q3 2025), and -$0.01 (Q2 2025).